Digital CRO Clinipace grabs $15M round

Clinipace Worldwide, a growing CRO with proprietary clinical trials software, has fueled the expansion of its business with a fresh $15 million Series C round. Morgan Stanley Expansion Capital led the round, which included investments from Hatteras Venture Partners and Brook Private Equity Advisors. With its restocked coffers, the Morrisville, NC-based contract research group will continue its growth with a focus on serving emerging and mid-sized biotechs along with medical device outfits. In recent years, the company has grown through multiple acquisitions. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.